3D Cell Culture
Total Trials
10
As Lead Sponsor
3
As Collaborator
7
Total Enrollment
4,625
NCT00130013
Efficacy of Single Versus Double Dose of Oral Amoxicillin for Non-Severe Pneumonia in Children
Phase: Phase 1/2
Role: Lead Sponsor
Start: Sep 30, 2003
Completion: Jun 30, 2004
NCT01375426
Efficacy Study for Standard Versus Double Dose of Amoxicillin in WHO Defined Non-severe Pneumonia
NCT01154673
Effects of Intensive cART During Acute/Early HIV Infection
Phase: Phase 2/3
Role: Collaborator
Start: Nov 30, 2011
Completion: Sep 30, 2014
NCT02149888
PRe-Exposure Prophylaxis Acceptability & Readiness Assessments for Toronto gaY, Bisexual and Other Men Who Have Sex With Men-5
Phase: Phase 4
Start: Oct 31, 2014
Completion: Jun 30, 2016
NCT02651428
Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream Infection
Phase: Phase 3
Start: Dec 31, 2015
Completion: Oct 31, 2018
NCT03594838
Evaluation of HCV Viremia Testing Approaches Among PWID in Georgia
Phase: N/A
Start: May 21, 2018
Completion: Jul 21, 2020
NCT05097430
PrEP and Alcohol - Enhancing HIV Pre-Exposure Prophylaxis (PrEP)
Start: Sep 28, 2021
Completion: Aug 31, 2024
NCT05381961
Observational Study of BIS in Hemodialysis Patients
Start: Apr 4, 2022
Completion: Sep 30, 2023
NCT05663892
Drug-Drug Interaction Study in Trans Women Living With HIV
Start: Nov 23, 2022
Completion: Jan 31, 2025
NCT06823596
"The T Cell Activator of Cell Killing (TACK) IT ON STUDY"
Start: Jan 14, 2025
Completion: Sep 1, 2026
Loading map...